ACTIVE

EVRAS

Financial year 2025 · Closed on 31/12/2025

Net result1,6 k €+111,2 %over 1 year

Gross margin47,1 k €+51,0 %over 1 year

Equity57,3 k €+2,8 %over 1 year

Identity

Source · BCE/KBO

EVRAS is a Public limited company incorporated in 1977. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Frameries.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0417.723.174
Incorporation: 25/11/1977
Legal form: Public limited company
Registered office: Rue Montavaux 155
7080 Frameries · WallonieSee on map
Contributed capital: 195 300,00 €
Latest accounts: 31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 47750Retail sale of cosmetic and toilet articles in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores 52330Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	47,1 k €	+51.0%	31,2 k €	+311%	-14,8 k €	-113%	116,8 k €	+189%	40,4 k €
EBITDA	43,2 k €	+60.0%	27 k €	+227%	-21,3 k €	-119%	112,6 k €	+20727%	-546 €
Operating result	1,8 k €	+112%	-14,5 k €	+76.9%	-62,8 k €	-205%	59,9 k €	+231%	-45,7 k €
Net result	1,6 k €	+111%	-13,9 k €	+70.1%	-46,5 k €	-162%	74,7 k €	+326%	-33 k €
Balance sheet
Equity	57,3 k €	+2.8%	55,8 k €	-20.0%	69,7 k €	-40.0%	116,2 k €	+180%	41,5 k €
Total assets	133,1 k €	-13.1%	153,1 k €	-59.6%	379,2 k €	-4.0%	394,9 k €	-0.6%	397,4 k €
Cash	19,7 k €	+313%	4,8 k €	-92.0%	60 k €	-3.2%	62 k €	+135%	26,3 k €
Debts	75,7 k €	-22.2%	97,4 k €	-68.5%	309,5 k €	+11.1%	278,6 k €	-21.7%	355,9 k €
Other
Workforce	–		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMARepresented by Philippe Boulanger	Director18/03/2022 → 17/03/2028
GESTIPHARMA0425.530.684Represented by PIERRE PASCAL HECQ	Managing director19/02/2015 → 17/03/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FELIX PHARMA0477.939.091	Director18/02/2021 → 2022 accounts
UNIVERSAL PHARMA0447.382.113	Director18/02/2021 → 2022 accounts

Other companies at this address

Rue Montavaux 155 7080 Frameries

Company	CBE no.
ASSCOT● Active	0447.778.625
ATRIUM MANAGEMENT● Active	0478.169.913
BEPHAR● Active	0450.260.538
FARMIMMO● Active	0429.198.175
FELIX PHARMA● Active	0477.939.091
IMMOBILIERE DES QUATRE SEIGNEURIES● Active	0443.155.782
Immobilière Général Léman● Active	0403.358.761
IMMOBILIERE PRIMA● Active	0466.956.812
IMMOBILIERE SAINT GEORGES● Active	0435.700.442
Les Pharmacies Réunies● Active	0403.082.213
OBIPHAR● Active	0878.100.418
PHARMACIE ANDROMEDE● Active	0882.318.631
PHARMACIE CLAERHOUT● Active	0423.162.203
Pharmacie de la Chasse Royale● Active	0867.368.654
PHARMACIE DE LA PLACE DE GHLIN● Active	0842.900.009
PHARMACIE FAIDHERBE● Active	0479.179.208
Pharmacie Grenez - Seeuws● Active	0419.745.130
PHARMACIE RONDEAU● Active	0447.088.737
PHARMACIE SCHNEIDER - DEPOUHON● Active	0439.400.397
PHARMANET● Active	0426.485.640

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/10/2021	01/10/2020	01/10/2019
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	30/09/2021	30/09/2020
Length of the financial year	12 months	12 months	12 months	15 months	12 months	12 months
Filing date	30/06/2026	14/07/2025	06/08/2024	23/08/2023	22/03/2022	01/04/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	30/06/2023	17/02/2022	18/02/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	26/06/2026	30/06/2026	French	PDF
Micro model	31/12/2024	27/06/2025	14/07/2025	French	PDF
Micro model	31/12/2023	28/06/2024	06/08/2024	French	PDF
Micro model	31/12/2022	30/06/2023	23/08/2023	French	PDF
Micro model	30/09/2021	17/02/2022	22/03/2022	French	PDF
Abridged model	30/09/2020	18/02/2021	01/04/2021	French	PDF
Abridged model	30/09/2019	20/02/2020	03/03/2020	French	PDF
Abridged model	30/09/2018	21/02/2019	01/03/2019	French	PDF
Abridged model	30/09/2017	15/02/2018	27/03/2018	French	PDF
Abridged model	30/09/2016	16/02/2017	23/02/2017	French	PDF
Abridged model	30/09/2015	18/02/2016	05/12/2016	French	PDF
Abridged model	30/09/2014	19/02/2015	27/03/2015	French	PDF
Abridged model	30/09/2013	20/02/2014	29/04/2014	French	PDF
Abridged model	30/09/2012	21/02/2013	04/03/2013	French	PDF
Abridged model	30/09/2011	16/02/2012	08/03/2012	French	PDF
Abridged model	30/09/2010	17/02/2011	29/03/2011	French	PDF
Abridged model	30/09/2009	18/02/2010	31/03/2010	French	PDF
Abridged model	30/09/2008	19/02/2009	19/02/2009	French	PDF
Abridged model	30/09/2007	21/02/2008	22/02/2008	French	PDF
Abridged model	30/09/2006	15/02/2007	15/03/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMARepresented by Philippe Boulanger	Director18/03/2022 → 17/03/2028
GESTIPHARMA0425.530.684Represented by PIERRE PASCAL HECQ	Managing director19/02/2015 → 17/03/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FELIX PHARMA0477.939.091	Director18/02/2021 → 2022 accounts
UNIVERSAL PHARMA0447.382.113	Director18/02/2021 → 2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates04/12/2024
Reconductions d'administrateurs et administrateur-délégué.,
PDF
Mandates10/05/2022
DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates07/06/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates06/03/2017
Démission d'Administrateurs - Nomination d'Administrateurs et
PDF
Mandates29/04/2015
DEMISSIONS, NOMINATIONS
PDF
Capital / shares17/12/2013
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates19/06/2009
RENOUVELLEMENT DES MANDATS - NOMINATION ADMINISTRATEUR
PDF
Mandates04/04/2007
RENOUVELLEMENT MANDATS ADMINISTRATEURS ‘
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

GESTIPHARMA

FINPHARMA

UNIVERSAL PHARMA

FELIX PHARMA

Nelly COQUIART

Dominique HAVERBEKE

Michèle EVRAS

1977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

EVRAS

Rue Montavaux 155, 7080 Frameries

Managing director

Director

Managing director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Montavaux 155, 7080 FrameriesCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00242935

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
EVRASCurrent	accounts 2007 → 2025	Accounts 2025 · 2026-00242935

Events

2025
Annual accounts 20251,6 k €↑
2024
Annual accounts 2024-13,9 k €↑
2023
Annual accounts 2023-46,5 k €↓
2022
Annual accounts 202274,7 k €↑
2021
Annual accounts 2021-33 k €↓
2020
Annual accounts 2020-31,2 k €↑
2019
Annual accounts 2019-71,1 k €↓
2018
Annual accounts 2018-59,5 k €↓
2017
Annual accounts 2017-37,8 k €↓
2016
Annual accounts 20163,4 k €↓
2015
Annual accounts 201531 k €↑
2014
Annual accounts 201421 k €↑
2013
Annual accounts 201317,2 k €↑
2012
Annual accounts 20128,3 k €↓
2011
Annual accounts 20118,4 k €↓
2010
Annual accounts 201012,9 k €↑
2009
Annual accounts 200912,5 k €↑
2008
Annual accounts 20089,7 k €↑
2007
Annual accounts 20071,9 k €
25/11/1977
IncorporationPublic limited company

EVRAS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events